Features of Top Medical Device Companies

CardioMEMS' 11-year payoff worth the wait for Boston Millennia Partners

July 31, 2014 by Brian Johnson

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.

Podcast: CEO Brian Concannon on the past and future for Haemonetics at MassDevice.com's DeviceTalks

July 23, 2014 by Brian Johnson

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

More than a year ago, Haemonetics (NYSE:HAE) launched a major restructuring effort, moving nearly 300 manufacturing jobs out of the country in an effort to cut between $35 million and $40 million by fiscal 2018.

The cuts were painful, not only for the 42-year-old blood management company and its workers, but for CEO Brian Concannon, who grew up only a stone's throw from the company's headquarters in Braintree, Mass.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

July 10, 2014 by Brad Perriello

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

For years the Holy Grail of ophthalmology has been to give patients the ability to see clearly both and near and far distances. Verne Sharma, CEO of Calhoun Vision, thnks his company's light-adjustable lens has reached that goal.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

July 7, 2014 by Arezu Sarvestani

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Digital health is all the rage in Silicon Valley, especially as consumer technology's biggest players are getting more interested in tracking health and fitness. But for companies like iRhythm, the health side of the equation comes first.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at DeviceTalks

July 1, 2014 by Brian Johnson

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

MassDevice.com sat down with Stacy Enxing Seng, executive in residence at Covidien (NYSE:COV), just a week after the company announced it had agreed to be acquired by Medtronic (NYSE:MDT) for $43 billion.

FDA cybersecurity rejections are on the way

June 5, 2014 by Arezu Sarvestani

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

FDA cybersecurity rejections are on the way

Although the FDA has only recently begun addressing medical device cybersecurity in an official capacity, device makers would do well to take notice that the agency has ramped up its oversight quickly over the last year.

Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent

June 2, 2014 by Brad Perriello

Transcend Medical CEO Brian Walsh tells MassDevice.com why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Brian Walsh looks to transcend glaucoma treatment with micro-stent

Until recently, the treatment for glaucoma – a group of diseases that cause pressure within the eyeball – consisted of several options, none of them ideal. Patients could opt for medicines, either oral or via eyedrops, to lower eye pressure. A surgical option that in essence creates a drain in the eyeball for ocular fluid is also available, as is a procedure call laser trabeculoplasty that also creates a drainage pathway.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Integrity Applications looks beyond optical for blood glucose

May 28, 2014 by Brad Perriello

Integrity Applications looks beyond optical sensors with its GlucoTrack Model DF-F, which uses ultrasonic, electromagnetic and thermal technology to measure physiological changes associated with blood glucose levels.

Diabetes: Integrity Applications looks beyond optical for blood glucose

A 23-year career in the Israeli Navy might not seem like the ideal background for a medical device company chief, but for Integrity Applications chairman & CEO Avner Gal it turned out to be the perfect pedigree.

Backboard to boardroom: Jonathan Bender's journey from NBA star to medtech entrepreneur

May 26, 2014 by Brian Johnson

Former NBA player Jonathan Bender tries his hand at entrepreneurship, aiming to bring the physical therapy device he invented to the U.S. market.

JB photo

Joint pain cut years from Jonathan Bender's professional basketball career, but it also gave him a future.

The former NBA player, who made the jump from high school directly to the pros in 1999, spent 7 injury-plagued seasons with the Indiana Pacers before bowing out in 2006 (Bender returned in 2010 for a half season with the New York Knicks).

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Engineering disruption: R&D firm Battelle pulls inspiration from surprising sources

May 23, 2014 by Arezu Sarvestani

Battelle engineering manager Melissa Masters tells MassDevice.com how insights ranging from national security to aeronautics can inform the creation of disruptive new medical devices.

Turning diversification into disruption: Battelle pulls inspiration from surprising sources

Medical device executives and Ted Talk-ers love comparing the medtech industry to consumer electronics or aeronautics when making grand points about the market, but at Battelle cross-industry correlations speak to the core of the company’s engineering philosophy.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp